Document:

Second Amendment to Development and Commercialization Agreement

 EXHIBIT 10.36.2 
 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED
BY BRACKETS, IS 
 FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE 
 SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  
  
 February 13, 2009 
  
 Mr. Simon Bicknell 

Company Secretary 
 Glaxo Group Limited

 Glaxo Wellcome House 
 Berkeley
Avenue 
 Greenford, Middlesex, UB6 0NN 
 UNITED KINGDOM 
  

	Re:	 Second Amendment to Development and Commercialization Agreement between XenoPort, Inc. (“XenoPort”) and Glaxo Group Limited
(“GSK”) dated February 7, 2007, as amended by that certain First Amendment, dated May 4, 2007 (as amended to date, the “Agreement”) 

 Dear Mr. Bicknell: 
 This letter (the “Second
Amendment”) is to confirm the agreement between XenoPort and GSK with respect to an amendment to the Agreement as set out in Paragraphs 1 – 16 below. All capitalized terms not otherwise defined in this Second Amendment shall have the
respective meanings given to such terms in the Agreement. XenoPort and GSK agree that, effective February 13, 2009 (the “Second Amendment Date”), the Agreement shall be further amended as follows: 
 1.        Section 1.17 shall be deleted and restated in its entirety as follows: 

“1.17    “Detail” (including any variations such as
“Detailing”) shall mean that part of the activity undertaken by a Sales Representative during a Call whereby a Sales Representative, who has been trained with respect to the REQUIPTM Product and/or the Product, as applicable, in
accordance with Section 5.4(c), makes a face-to-face presentation: (a) describing [... * ...] as applicable; (b) which may also include [... * ...]; and (c) in accordance with the
[... * ...], as applicable. [... * ...], shall not constitute a Detail. [... * ...], as applicable, shall not constitute a Detail. Only [... * ...] will
constitute [... * ...]. As used herein, a [... * ...] in which [... * ...] (as consistent with industry norms [... * ...], and a
[... * ...].” 
 2.      New Section 1.28 shall be added to
the Agreement as follows (and all subsequent definitions in Section 1 and related section references shall be deemed renumbered accordingly): 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 

 “1.28    “Loss of Exclusivity Date” shall mean
the earliest of: (a) [... * ...]; (b) [... * ...]; and (c) the date that the REQUIPTM Product is withdrawn from the United States market. The term
[... * ...].” 
 3.        Section 1.48 of the
Agreement (formerly Section 1.47) shall be deleted and restated in its entirety as follows: 
 “1.48    “REQUIPTM Product” shall mean that certain pharmaceutical product Controlled by GSK or its Affiliates as of the Effective Date, which contains ropinirole HCL as an active ingredient and
is known as of the Second Amendment Date as REQUIPTM XL.” 
 (a) All references to “REQUIPTM Products”
in Sections 1.4 “Applicable Commercial Practices Policies,” 1.17 “Detail,” 1.45 (formerly 1.44) “Promotional Materials,” 1.51 (formerly 1.50) “Sales Representative,” 1.52 (formerly 1.51) “Samples,”
1.54 (formerly 1.53) “Target Audience,” 5.3, , 5.3(c), 5.3(e), 5.3(e)(i-vii), 5.4(a), 5.4(b), 5.4(c), 5.4(g), 5.4(j), 5.5. 5.6(c), 5.7(a), 5.9(a), 5.9(b)(iii), 5.9(d), 5.9(e), 5.9(f), 9.1(b), 15.2(i), 17.1 and Exhibit 5 of the Agreement
shall be replaced with the words “REQUIPTM Product” in each such Section. 
 4.        Section 1.49 of the Agreement (formerly Section 1.48) shall be deleted and restated in its entirety as follows: 
 “1.49    “REQUIPTM Trademark” shall mean the Trademark Controlled by GSK or
its Affiliates as of the Effective Date and during the Term, which is used with the REQUIPTM Product in the Field in the Territory.” 
 (a) All references to “REQUIPTM Trademarks” in Exhibit 5 of the Agreement shall be replaced with the words “REQUIPTM Trademark.” 
 5.        All references to “Exhibit 1.59” in Section 1.60 “XenoPort
Patents” (formerly Section 1.59) and Exhibit 1.59 of the Agreement shall be replaced with the words “Exhibit 1.60” in each such Section. 
 6.        All references to “Exhibit 1.60” in Section 1.61 “XenoPort Trademarks” (formerly Section 1.60) and Exhibit
1.60 of the Agreement shall be replaced with the words “Exhibit 1.61” in each such Section. 
 7.        A reference to “REQUIPTM Co-Promotion Date” as defined in Section 5.3(a) shall be added to the Additional Definitions set forth in Section 1.62 (formerly
Section 1.61). A reference to “REQUIPTM Option” as defined in Section 5.3(a) shall be added to the Additional Definitions set forth in Section 1.62. References to “Primary Detail” and “Secondary
Detail” as defined in Section 1.17 shall be added to the Additional Definitions set forth in Section 1.62. 
 8.        The second sentence of Section 5.2(b) of the Agreement shall be deleted and restated in its entirety as follows: 
 “The Co-Promotion Plan shall set out in reasonable detail: (i) [... * ...] in connection
with the Co-Promotion [... * ...]; (ii) [... * ...]; (iii) [... * ...]; and (iv) [... * ...].” 
 9.        The first two sentences of Section 5.2(e) of the Agreement shall be deleted and
restated in their respective entireties as follows: 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 

 “(e)        Sales Effort
of XenoPort.    In the event that XenoPort has exercised the Co-Promotion Option, then upon the earlier to occur of the REQUIPTM Co-Promotion Date and the date the Product receives Marketing Approval in the United States,
XenoPort shall notify GSK of the number of Sales Representatives that XenoPort elects to deploy initially for the Product, provided that [... * ...]. Promptly after such notification, [... * ...],
XenoPort will [... * ...] of Sales Representatives that XenoPort so elects; [... * ...] of Sales Representatives to provide Details of the Product in accordance with the Co-Promotion Plan.”

 10.        Sections 5.3(a), 5.3(b) and 5.3(d) of the Agreement shall be deleted
and restated in their respective entireties as follows: 
 “(a)        Commencement of Right to Detail the REQUIPTM Product.    If XenoPort exercises the Co-Promotion Option for the Product, XenoPort shall also obtain a
non-sublicensable, non-exclusive option to Detail the REQUIPTM Product in the United States in accordance with the terms of this Article 5 (the “REQUIPTM Option”). XenoPort may exercise the REQUIPTM Option by notifying
GSK in writing [... * ...] (the date on which XenoPort notifies GSK of its election to exercise the REQUIPTM Option pursuant to this Section 5.3(a) shall be the “REQUIPTM Co-Promotion Date”). In
the event that XenoPort exercises the REQUIPTM Option as provided in this Section 5.3(a), XenoPort will have a non-exclusive, non-sublisenable right to Detail the REQUIPTM Product in accordance with the terms of this Article 5 in the
United States until [... * ...]; provided, however, that [... * ...]. In the event that XenoPort does not exercise the REQUIPTM Option as provided in this Section 5.3(a) prior to
[... * ...], XenoPort will have no right to Detail the REQUIPTM Product in the United States, and GSK will have no further obligation with respect to the REQUIPTM Option. 
 (b)        The REQUIPTM Sales Plan.    GSK shall
prepare and determine, in consultation with XenoPort, the tactical plan for XenoPort’s Detailing of the REQUIPTM Product by XenoPort Sales Representatives in the United States (the “REQUIPTM Sales Plan”) and shall
provide the REQUIPTM Sales Plan to XenoPort [... * ...]. The REQUIPTM Sales Plan shall set out in reasonable detail: (i) [... * ...] in connection with [... * ...];
and (iii) [... * ...] under such REQUIPTM Sales Plan, [... * ...] and which is [... * ...]. XenoPort shall be entitled to dedicate a number of Sales Representatives
elected by XenoPort, up to [... * ...], to Detail the REQUIPTM Product in the United States. XenoPort’s right to deploy such Sales Representatives shall commence [... * ...].” 

“(d)        Reimbursement.    GSK shall
reimburse XenoPort for each Detail provided by the XenoPort Sales Representatives Detailing the REQUIPTM Product in the United States in accordance with the REQUIPTM Sales Plan. Such reimbursement shall be equal to
[... * ...]; provided, however that if during the Call in which the XenoPort Sales Representative is Detailing the REQUIPTM Product, the XenoPort Sales Representative is Detailing a pharmaceutical product other than the
Product or the REQUIPTM Product, then GSK shall reimburse XenoPort [... * ...]. For the purposes of example only: 
 (A)        If, during a Call, a XenoPort Sales Representative is only Detailing the REQUIPTM Product, then XenoPort will be entitled to receive
$[... * ...] for such Detail. 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 

 (B)        If, during a Call, a
XenoPort Sales Representative is only Detailing the REQUIPTM Product and the Product, then XenoPort will be entitled to receive $[... * ...] for such Detail of the REQUIPTM Product and
$[... * ...] for such Detail of the Product. 
 (C)        If, during a Call, a XenoPort Sales Representative is Detailing the REQUIPTM Product, Product and another pharmaceutical product, then XenoPort will be entitled to receive
$[... * ...] for such Detail of the REQUIPTM Product and $[... * ...] for such Detail of the Product. 
 Such reimbursements shall be made to XenoPort [... * ...].” 
 11.        Section 5.4(d) of the Agreement shall be deleted and restated in its entirety as follows: 
 “(d)        Timing.    XenoPort and GSK shall
cooperate to have the XenoPort Sales Representatives hired and trained as provided in this Agreement [... * ...] prior to [... * ...].” 
 12.        Section 5.8 of the Agreement shall be deleted and restated in its entirety as
follows: 
 “5.8        Reimbursement.    Within [... * ...], XenoPort shall submit to GSK a report containing an accounting of the Sales Representatives
deployed by XenoPort in Co-Promoting and Detailing the Product and/or Detailing the REQUIPTM Product (as the case may be) in the United States and [... * ...]. Such reimbursements shall be made to XenoPort
[... * ...]. The amount of such reimbursement shall be as specified in Section 5.2(f) and/or 5.3(d), as applicable.” 
 13.        Sections 5.9(b)(i), 5.9(b)(ii) and 5.9(c) of the Agreement shall be deleted and restated in their respective entireties as follows: 

“(b)(i)    As to the Product.    After XenoPort has commenced its
Detailing of the Product, GSK shall have the right to terminate XenoPort’s right to Co-Promote and Detail the Product: (A) [... * ...] in accordance with the Co-Promotion Plan)
[... * ...]; and/or (B) [... * ...] with respect to [... * ...]. 
 (ii)        As to the REQUIPTM Product.    After XenoPort has exercised the Co-Promotion Option and following [... * ...],
GSK shall have the right to [... * ...] terminate XenoPort’s right to Detail the REQUIPTM Product upon [... * ...].” 
 “(c)        Extension of the REQUIPTM Product
Detailing.    GSK shall notify XenoPort in writing, [... * ...], as to whether GSK, in its sole discretion, elects to extend XenoPort’s right to Detail the REQUIPTM Product after the
[... * ...] If GSK so notifies XenoPort of such extension, XenoPort’s right to Detail the REQUIPTM Product will continue after the [... * ...].” 
 14.        The Milestone Event described in number 7 of Section 6.2(a) of the Agreement
shall be deleted and restated in its entirety as follows: 
 “7. [... * ...]” 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 

 15.        All references to “Section
1.33” in Section 6.3(c) and 18.2 of the Agreement shall be replaced with the words “Section 1.34” in each such Section. 
 16.        Section 8.2 of the Agreement shall be deleted and restated in its entirety as follows: 
 “8.2        Diligent Efforts of
XenoPort.    XenoPort shall use Commercially Reasonable Efforts to conduct the Clinical Studies and Activities and, in the event that it exercises the Co-Promotion Option and/or the REQUIPTM Option, as applicable, use
Commercially Reasonable Efforts in its Co-Promotion and Detailing of the Product and/or Detailing of the REQUIPTM Product, as applicable, following the Marketing Approval of the Product in the United States and/or the REQUIPTM Co-Promotion
Date, as applicable.” 
 Except as specifically provided in this Second Amendment, no provision of the Agreement shall
be modified or amended hereby and all provisions of the Agreement shall remain in full force and effect. The Agreement, as specifically modified and amended by this Second Amendment, is hereby confirmed and approved. This Second Amendment and all
questions regarding its validity or interpretation shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without reference to conflict of law principles. 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 

 Please confirm GSK’s acceptance of, and agreement with, this Second Amendment by
signing, or having an authorized representative of GSK sign, two (2) copies of this Second Amendment and return one (1) original copy and one (1) photocopy of the Second Amendment to: 
  
  

			
	 Originally executed copy to:
  
 XenoPort, Inc.
 3410 Central
Expressway
 Santa Clara, CA 95051
 Facsimile: (408) 616-7211
 Attention: Secretary
	  	 And a copy to:
  
 Wilson, Sonsini, Goodrich & Rosati
 650
Page Mill Road
 Palo Alto, CA 94304
 Facsimile: (650) 493-6811
 Attention: Kenneth A. Clark

 Yours sincerely, 
  

	
	
	 /s/ William J. Rieflin

	 William J. Rieflin
 President

  
  

			
	 ACKNOWLEDGED AND AGREED BY GLAXO GROUP LIMITED:

	
	 /s/ Paul Williamson

		
	 Name:
	 	 Paul Williamson

		
	Title:	 	 For and on behalf of Edinburgh Pharmaceutical Industries Limited

		
	 	 	 Corporate Director

		
	Date:	 	  

  

	cc:	 Adrian Rawcliffe 

 Senior Vice President, Worldwide Business Development, GlaxoSmithKline 
  

	cc:	 Chip Cale 

 Vice
President and Associate General Counsel, Business Development Transactions, GlaxoSmithKline 
  

  
  
 * CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED.Registration Rights Agreement

 Exhibit 4.1 
 Execution Version 
  
  
 $700,000,000 6.90% Senior Notes due 2019 
 $300,000,000 7.85% Senior Notes due 2039 
 REGISTRATION RIGHTS AGREEMENT 
 Dated as of February 13, 2009 
 by and among 
 NEWS AMERICA INCORPORATED, 
 NEWS CORPORATION 
 and 
 J.P. MORGAN SECURITIES INC. 
 as
Initial Purchaser 
  
  

 REGISTRATION RIGHTS AGREEMENT 
 THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 13, 2009 by and among NEWS AMERICA
INCORPORATED, a Delaware corporation (the “Issuer”), NEWS CORPORATION, a Delaware corporation (the “Guarantor”), and J.P. MORGAN SECURITIES INC. (the “Initial Purchaser”). 
 This Agreement is made pursuant to the Purchase Agreement, dated as of February 10, 2009, by and among the Issuer, the Guarantor and the Initial
Purchaser (the “Purchase Agreement”), which provides for, among other things, the sale by the Issuer to the Initial Purchaser of (i) an aggregate of $700,000,000 principal amount of the Issuer’s 6.90% Senior Notes Due 2019
(the “6.90% Senior Notes”) and (ii) an aggregate of $300,000,000 principal amount of the Issuer’s 7.85% Senior Notes Due 2039 (the “7.85% Senior Notes” and, together with the 6.90% Senior Notes, the
“Securities”). In order to induce the Initial Purchaser to enter into the Purchase Agreement, the Issuer has agreed to provide to the Initial Purchaser and its direct and indirect transferees the registration rights set forth in
this Agreement. The execution and delivery of this Agreement is a condition to the closing under the Purchase Agreement. 
 In consideration
of the foregoing, the parties hereto agree as follows: 
 1. Definitions. As used in this Agreement, the following capitalized defined
terms shall have the following meanings: 
 “6.90% Exchange Notes” shall mean the senior debt securities
issued by the Issuer under the Indenture containing terms identical to the 6.90% Senior Notes which terms shall include the guarantee of the Guarantor on the original 6.90% Senior Notes (except that (i) interest thereon shall accrue from the
last date on which interest was paid on the 6.90% Senior Notes or, if no such interest has been paid, from February 13, 2009 and (ii) the transfer restrictions thereon shall be eliminated) to be offered to Holders of 6.90% Senior Notes in
exchange for 6.90% Senior Notes pursuant to the Exchange Offer. 
 “6.90% Senior Notes” shall have the
meaning set forth in the preamble to this Agreement. 
 “7.85% Exchange Notes” shall mean the senior debt
securities issued by the Issuer under the Indenture containing terms identical to the 7.85% Senior Notes which terms shall include the guarantee of the Guarantor on the original 7.85% Senior Notes (except that (i) interest thereon shall accrue
from the last date on which interest was paid on the 7.85% Senior Notes or, if no such interest has been paid, from February 13, 2009 and (ii) the transfer restrictions thereon shall be eliminated) to be offered to Holders of 7.85% Senior
Notes in exchange for 7.85% Senior Notes pursuant to the Exchange Offer. 
 “7.85% Senior Notes” shall have
the meaning set forth in the preamble to this Agreement. 
 “Additional Interest” shall have the meaning set
forth in Section 2(e) hereof. 

 “Advice” shall have the meaning set forth in the last paragraph of
Section 3 hereof. 
 “Applicable Period” shall have the meaning set forth in Section 3(s) hereof.

 “Business Day” shall mean a day that is not a Saturday, a Sunday, or a day on which banking institutions
in New York, New York are required to be closed. 
 “Closing Time” shall mean the Closing Time as defined in
the Purchase Agreement. 
 “Depositary” shall mean The Depository Trust Company, or any other depositary
appointed by the Issuer; provided, however, that such depositary must have an address in the Borough of Manhattan, in The City of New York. 
 “Effectiveness Period” shall have the meaning set forth in Section 2(b) hereof. 
 “Event Date” shall have the meaning set forth in Section 2(e) hereof. 
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 
 “Exchange
Offer” shall mean the exchange offer by the Issuer of Exchange Securities for Securities pursuant to
 Section 2(a) hereof. 
 “Exchange Offer Registration” shall mean a registration under the Securities Act effected pursuant to Section 2(a) hereof. 
 “Exchange Offer Registration Statement” shall mean an exchange offer registration statement on Form S-1 or S-4 (or, if
applicable, on another appropriate form), and all amendments and supplements to such registration statement, in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference therein.

 “Exchange Period” shall have the meaning set forth in Section 2(a)(ii) hereof. 
 “Exchange Securities” shall mean the 6.90% Exchange Notes and the 7.85% Exchange Notes. 
 “Holder” shall mean the Initial Purchaser, for so long as it owns any Registrable Securities, and each of its successors,
assigns and direct and indirect transferees who become registered owners of Registrable Securities under the Indenture. 
 “Indenture” shall mean the Amended and Restated Indenture relating to the Securities, dated as of March 24, 1993, among the Company as issuer of the Securities, the guarantors named therein, and The Bank of New York,
as trustee (the “Trustee”), and as supplemented by a First Supplemental Indenture, dated as of May 20, 1993, a Second Supplemental Indenture, dated as of May 28, 1993, a Third Supplemental Indenture, dated as of July 21,
1993, a Fourth Supplemental Indenture, dated as of October 20, 1995, a Fifth 

  

 2 

 
Supplemental Indenture, dated as of January 8, 1998, a Sixth Supplemental Indenture, dated as of March 1, 1999, a Seventh Supplemental Indenture,
dated as of February 14, 2001, an Eighth Supplemental Indenture, dated as of July 27, 2003, a Ninth Supplemental Indenture, dated as of November 12, 2004, a Tenth Supplemental Indenture, dated as of March 14, 2005, an Eleventh
Supplemental Indenture, dated as of March 21, 2005, and a Twelfth Supplemental Indenture, dated as of May 23, 2007, as the same may be amended or supplemented from time to time in accordance with the terms thereof. 
 “Initial Purchaser” shall have the meaning set forth in the preamble to this Agreement. 
 “Inspectors” shall have the meaning set forth in Section 3(m) hereof. 
 “Issuer” shall have the meaning set forth in the preamble to this Agreement and also includes the Issuer’s
successors and permitted assigns. 
 “Majority Holders” shall mean the Holders of a majority of the aggregate
principal amount of outstanding Registrable Securities. 
 “Participating Broker-Dealer” shall have the
meaning set forth in Section 3(s) hereof. 
 “Person” shall mean an individual, partnership,
corporation, limited liability company, trust or unincorporated organization, or a government or agency or political subdivision thereof. 
 “Private Exchange” shall have the meaning set forth in Section 2(a) hereof. 
 “Private Exchange Securities” shall have the meaning set forth in Section 2(a) hereof. 
 “Prospectus” shall mean the prospectus included in a Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus supplement, including a prospectus
supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by a Shelf Registration Statement, and by all other amendments and supplements to a prospectus, including post-effective amendments, and in
each case including all material incorporated by reference therein. 
 “Purchase Agreement” shall have the
meaning set forth in the preamble to this Agreement. 
 “Records” shall have the meaning set forth in
Section 3(m) hereof. 
 “Registrable Securities” shall mean each Security and, if issued, each Private
Exchange Security until (i) the date on which such Security has been exchanged by a Person other than a Participating Broker-Dealer for an Exchange Security in the Exchange Offer, (ii) following the exchange by a Participating
Broker-Dealer in the Exchange Offer of a Security for an Exchange Security, the date on which such Exchange Security is sold to a purchaser who 

  

 3 

 
receives from such Participating Broker-Dealer on or prior to the date of such sale a copy of the Prospectus contained in the Exchange Offer Registration
Statement, as amended or supplemented, (iii) the date on which such Security or Private Exchange Security, as the case may be, has been effectively registered under the Securities Act and disposed of in accordance with the Shelf Registration
Statement, (iv) the date on which such Security or Private Exchange Security, as the case may be, is eligible for distribution to the public pursuant to Rule 144(k) under the Securities Act (or any similar provision then in force, but not Rule
144A under the Securities Act), (v) the date such Security or Private Exchange Security, as the case may be, shall have been otherwise transferred by the Holder thereof and a new Security not bearing a legend restricting further transfer shall
have been delivered by the Issuer and subsequent disposition of such Security shall not require registration or qualification under the Securities Act or any similar state law then in force or (vi) such Security or Private Exchange Security, as
the case may be, ceases to be outstanding. 
 “Registration Expenses” shall mean any and all expenses
incident to performance of or compliance by the Issuer with this Agreement, including without limitation: (i) all SEC, stock exchange or National Association of Securities Dealers, Inc. (the “NASD”) registration and filing fees,
including, if applicable, the reasonable fees and expenses of any “qualified independent underwriter” (and its counsel) that is required to be retained by the Initial Purchaser in accordance with the rules and regulations of the NASD,
(ii) all reasonable fees and expenses incurred in connection with compliance with state securities or “blue sky” laws (including reasonable fees and disbursements of counsel for any underwriters or the Initial Purchaser in connection
with “blue sky” qualification of any of the Exchange Securities or Registrable Securities) and compliance with the rules of the NASD, (iii) all reasonable expenses of any Persons (other than the Holders or Persons acting on the
request of the Holders) in preparing or assisting in preparing, word processing, printing and distributing any Registration Statement, any Prospectus and any amendments or supplements thereto, and in preparing or assisting in preparing, printing and
distributing any underwriting agreements and other documents relating to the performance of and compliance with this Agreement, (iv) all rating agency fees, (v) the reasonable fees and disbursements of counsel for the Issuer and the
Guarantor and of the independent certified public accountants of the Issuer and the Guarantor, including the expenses of any “cold comfort” letters required by or incident to such performance and compliance, (vi) the reasonable fees
and expenses of the Trustee, and any exchange agent or custodian, (vii) all fees and expenses incurred in connection with the listing, if any, of any of the Registrable Securities on any securities exchange or exchanges, (viii) any
reasonable fees and disbursements of any underwriter customarily required to be paid by the Issuer or sellers of securities and the reasonable fees and expenses of any special experts retained by the Issuer in connection with any Registration
Statement, and (ix) all reasonable fees of Paul, Hastings, Janofsky & Walker LLP who shall initially act as counsel to Holders of the Registrable Securities or any one counsel designated in writing by the Majority Holders to act as
counsel to the Holders of the Registrable Securities in connection with a Shelf Registration Statement, but excluding fees of counsel to the underwriters and underwriting discounts and commissions and transfer taxes, if any, relating to the sale or
disposition of Registrable Securities by a Holder. 
 “Registration Statement” shall mean any registration
statement of the Issuer which covers any of the Exchange Securities or Registrable Securities pursuant to the provisions of this Agreement, and all amendments and supplements to any such Registration Statement, including post-effective amendments,
in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference therein. 
  

 4 

 “SEC” shall mean the Securities and Exchange Commission. 
 “Securities” shall have the meaning set forth in the preamble to this Agreement. 
 “Securities Act” shall mean the Securities Act of 1933, as amended. 
 “Shelf Registration” shall mean a registration effected pursuant to Section 2(b) hereof. 
 “Shelf Registration Statement” shall mean a “shelf” registration statement of the Issuer pursuant to the
provisions of Section 2(b) hereof which covers all of the Registrable Securities or all of the Private Exchange Securities, as the case may be, on an appropriate form under Rule 415 under the Securities Act, or any similar rule that may be
adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference
therein. 
 2. Registration Under the Securities Act. 
 (a) Exchange Offer. To the extent not prohibited by any applicable law or applicable SEC policy, the Issuer shall, for the benefit of the
Holders, at the Issuer’s cost (i) file with the SEC within 90 days after the Closing Time an Exchange Offer Registration Statement on an appropriate form under the Securities Act covering the offer by the Issuer to the Holders to
exchange all of the Registrable Securities (other than Private Exchange Securities, if issued) for a like principal amount of Exchange Securities, (ii) use its reasonable best efforts to cause such Exchange Offer Registration Statement to be
declared effective under the Securities Act by the SEC on or prior to the 180th day after the Closing Time, (iii) use its reasonable best efforts to have such Registration Statement remain effective until the closing of the Exchange Offer and
(iv) commence the Exchange Offer and use its reasonable best efforts to issue Exchange Securities in exchange for all Registrable Securities (other than the Private Exchange Securities, if issued) properly tendered prior thereto in the Exchange
Offer not later than 225 days after the Closing Time. Upon the effectiveness of the Exchange Offer Registration Statement, the Issuer shall promptly commence the Exchange Offer, it being the objective of such Exchange Offer to enable each Holder
eligible and electing to exchange Registrable Securities (other than Private Exchange Securities, if issued) for Exchange Securities (assuming that such Holder is not an affiliate of the Issuer within the meaning of Rule 405 under the Securities Act
and is not a broker-dealer tendering Registrable Securities acquired directly from the Issuer for its own account, acquires the Exchange Securities in the ordinary course of such Holder’s business and has no arrangements or understandings with
any Person to participate in the Exchange Offer for the purpose of “distributing” (within the meaning of the Securities Act) the Exchange Securities), with such Exchange Securities, from and after their receipt, having no limitations or
restrictions on their transfer under the Securities Act and under state securities or “blue sky” laws. 
  

 5 

 In connection with the Exchange Offer, the Issuer shall: 
 (i) mail to each Holder a copy of the Prospectus forming part of the Exchange Offer Registration Statement, together with an appropriate
letter of transmittal and related documents; 
 (ii) keep the Exchange Offer open for acceptance for a period of not less than
20 Business Days after the date notice thereof is mailed to the Holders (or longer if required by applicable law) (such period referred to herein as the “Exchange Period”); 
 (iii) utilize the services of the Trustee for the Exchange Offer; 
 (iv) permit Holders to withdraw tendered Securities at any time prior to the close of business, New York time, on the last Business Day of
the Exchange Period, by sending to the institution specified in the notice a telegram, telex, facsimile transmission or letter setting forth the name of such Holder, the principal amount of Securities delivered for exchange and a statement that such
Holder is withdrawing such Holder’s election to have such Securities exchanged; 
 (v) notify each Holder that any
Security not tendered will remain outstanding and continue to accrue interest, but will not retain any rights under this Agreement (except in the case of the Initial Purchaser and Participating Broker-Dealers as provided herein); and 
 (vi) otherwise comply in all respects with all applicable laws relating to the Exchange Offer. 
 If, prior to consummation of the Exchange Offer, the Initial Purchaser holds any Securities acquired by it and having the status of an
unsold allotment in the initial distribution, the Issuer upon the request of the Initial Purchaser shall, simultaneously with the delivery of the Exchange Securities in the Exchange Offer, issue and deliver to the Initial Purchaser in exchange (the
“Private Exchange”) for the Securities held by the Initial Purchaser, a like principal amount of debt securities of the Issuer that are identical (except that such securities shall bear appropriate transfer restrictions) to the
Exchange Securities (the “Private Exchange Securities”). 
 The Private Exchange Securities, if any, shall be
issued under the Indenture. The Private Exchange Securities shall be of the same series as, and the Issuer shall use its reasonable best efforts to have the Private Exchange Securities bear the same CUSIP number as, the applicable Exchange
Securities. 
 As soon as practicable after the close of the Exchange Offer and/or the Private Exchange, as the case may be,
the Issuer shall: 
 (i) accept for exchange all Securities or portions thereof tendered and not validly withdrawn pursuant to
the Exchange Offer; 
 (ii) accept for exchange all Securities duly tendered pursuant to the Private Exchange; and 

 

 6 

 (iii) deliver, or cause to be delivered, to the Trustee for cancellation all Securities
or portions thereof so accepted for exchange by the Issuer, and issue, and cause the Trustee under the Indenture to promptly authenticate and deliver to each Holder, a new Exchange Security or Private Exchange Security, as the case may be, equal in
principal amount to the principal amount of the Securities surrendered by such Holder and accepted for exchange. 
 To the
extent not prohibited by any law or applicable interpretation of the staff of the SEC, the Issuer shall use its reasonable best efforts to complete the Exchange Offer as provided above, and shall comply with the applicable requirements of the
Securities Act, the Exchange Act and other applicable laws in connection with the Exchange Offer. The Exchange Offer shall not be subject to any conditions, other than that the Exchange Offer does not violate applicable law or any applicable
interpretation of the staff of the SEC. Each Holder of Registrable Securities (other than Private Exchange Securities, if issued) who wishes to exchange such Registrable Securities (other than Private Exchange Securities, if issued) for Exchange
Securities in the Exchange Offer will be required to make certain customary representations in connection therewith, including representations that such Holder is not an affiliate of the Issuer within the meaning of Rule 405 under the Securities
Act, or if it is such an affiliate, it will comply with the registration and prospectus delivery requirements of the Securities Act to the extent applicable, that any Exchange Securities to be received by it will be acquired in the ordinary course
of business and that at the time of the commencement of the Exchange Offer it has no arrangement with any Person to participate in the distribution (within the meaning of the Securities Act) of the Exchange Securities. The Issuer shall inform the
Initial Purchaser, after consultation with the Trustee and the Initial Purchaser, of the names and addresses of the Holders to whom the Exchange Offer is made, and the Initial Purchaser shall have the right to contact such Holders and otherwise
facilitate the tender of Registrable Securities in the Exchange Offer. 
 Upon consummation of the Exchange Offer in
accordance with this Section 2(a), the provisions of this Agreement shall continue to apply, mutatis mutandis, solely with respect to Registrable Securities that are Private Exchange Securities, if issued, and Exchange Securities held by
Participating Broker-Dealers, and the Issuer shall have no further obligation to register Registrable Securities (other than Private Exchange Securities, if issued) pursuant to Section 2(b) hereof. 
 (b) Shelf Registration. To the extent not prohibited by any law or applicable SEC policy, in the event that (i) the Issuer is
not permitted to file the Exchange Offer Registration Statement or to consummate the Exchange Offer because the Exchange Offer is not permitted by applicable law or SEC policy, (ii) the Exchange Offer is not for any other reason declared
effective under the Securities Act by the SEC within 180 days after the Closing Time, (iii) any holder of Securities notifies the Issuer within 30 days after the commencement of the Exchange Offer that (1) due to a change in law or SEC
policy it is not entitled to participate in the Exchange Offer, (2) due to a change in law or SEC policy it may not resell the Exchange Securities acquired by it in the Exchange Offer to the public without delivering a Prospectus and the
Prospectus contained in the Exchange Offer Registration Statement is not appropriate or available for such resales by such holder or (3) it is a broker-dealer and owns Securities acquired directly from the Issuer or an affiliate of the Issuer,
or (iv) the holders of a majority in aggregate 

  

 7 

 
principal amount at maturity of the Securities may not resell the Exchange Securities acquired by them in the Exchange Offer to the public without
restriction under the Securities Act and without restriction under applicable “blue sky” or state securities laws, then in the case of any of (i) through (iv), the Issuer shall, at its cost, file as promptly as practicable after such
determination or date, as the case may be, and, in any event, prior to the later of (A) 90 days after the Closing Time or (B) 30 days after such filing obligation arises (provided, however, that if the Exchange Offer
Registration Statement is not declared effective under the Securities Act by the SEC within 180 days after the Closing Time, then the Issuer shall file the Shelf Registration Statement with the SEC on or prior to the 210th day after the Closing
Time, unless the Issuer has consummated the Exchange Offer prior to the 180th day after the Closing Time whereby the Issuer’s obligation to file a Shelf Registration Statement pursuant to clause (b)(ii) above shall be cancelled,
provided, that such cancellation shall not relieve the Issuer of any obligation to pay Additional Interest, if Additional Interest is otherwise due and payable), a Shelf Registration Statement providing for the sale by the Holders of all of
the Registrable Securities affected thereby, and, to the extent not declared effective automatically by the SEC, shall use its reasonable best efforts to cause such Shelf Registration Statement to be declared effective by the SEC as soon as
practicable and, in any event, on or prior to 90 days after the obligation to file the Shelf Registration Statement arises (in the case of (B) above). No Holder of Registrable Securities may include any of its Registrable Securities in any
Shelf Registration pursuant to this Agreement unless and until such Holder furnishes to the Issuer in writing, within 10 days after receipt of a request therefor, such information as the Issuer may, after conferring with counsel with regard to
information relating to Holders that would be required by the SEC to be included in such Shelf Registration Statement or Prospectus included therein, reasonably request for inclusion in any Shelf Registration Statement or Prospectus included
therein. Each Holder as to which any Shelf Registration is being effected agrees to furnish to the Issuer all information with respect to such Holder necessary to make any information previously furnished to the Issuer by such Holder not materially
misleading. 
 The Issuer agrees to use its reasonable best efforts to keep the Shelf Registration Statement continuously
effective, supplemented and amended for a period of two years from the Closing Time (or such shorter period provided for in any amendment to Rule 144(k) under the Securities Act (or any successor provision other than Rule 144A) upon the expiration
of which securities are eligible for distribution to the public) or such shorter period that will terminate when all the Registrable Securities covered by the Shelf Registration Statement have been sold pursuant thereto (subject to extension
pursuant to the last paragraph of Section 3 hereof) (the “Effectiveness Period”), provided, however, that with respect to the Private Exchange Securities, if issued, the Issuer shall only be obligated to keep the
Shelf Registration Statement effective, supplemented and amended for a period of 60 days. The Issuer shall not permit any securities other than Registrable Securities to be included in the Shelf Registration. The Issuer further agrees, if necessary,
to supplement or amend the Shelf Registration Statement, if required by the rules, regulations or instructions applicable to the registration form used by the Issuer for such Shelf Registration Statement or by the Securities Act or by any other
rules and regulations thereunder for shelf registrations, and the Issuer agrees to furnish to the Holders of Registrable Securities copies of any such supplement or amendment promptly after its being used or filed with the SEC. 
  

 8 

 Notwithstanding the requirements contained in this Section 2(b), solely with respect
to the Private Exchange Securities, if issued, the Issuer shall have no obligation to file or effect a Shelf Registration Statement registering such Private Exchange Securities if the aggregate principal amount of such Private Exchange Securities
does not exceed $5,000,000. 
 (c) Expenses. The Issuer shall pay all Registration Expenses in connection with any
registration pursuant to Section 2(a) or 2(b) hereof. Except as provided in the preceding sentence, each Holder shall pay all expenses of its counsel, underwriting discounts and commissions and transfer taxes, if any, relating to the sale or
disposition of such Holder’s Registrable Securities pursuant to the Shelf Registration Statement. 
 (d) Effective
Registration Statement. An Exchange Offer Registration Statement pursuant to Section 2(a) hereof or a Shelf Registration Statement pursuant to Section 2(b) hereof will not be deemed to have become effective unless it has been declared
effective by the SEC; provided, however, that if, after it has been declared effective, the offering of Registrable Securities pursuant to a Shelf Registration Statement is interfered with by any stop order, injunction or other order
or requirement of the SEC or any other governmental agency or court, such Shelf Registration Statement will be deemed not to have been effective during the period of such interference, until the offering of Registrable Securities may legally resume.
The Issuer will be deemed not to have used its reasonable best efforts to cause the Exchange Offer Registration Statement or the Shelf Registration Statement, as the case may be, to become, or to remain, effective during the requisite period if they
voluntarily take any action that would result in any such Registration Statement not being declared effective or in the Holders of Registrable Securities covered thereby not being able to exchange or offer and sell such Registrable Securities during
that period unless such action is required by applicable law. Notwithstanding the foregoing, the only remedy available under this Agreement for the failure of the Issuer to satisfy the obligations set forth in Sections 2(a), 2(b) and 3 hereof shall
be payment by the Issuer of the Additional Interest as set forth in Section 2(e) hereof and the remedy of specific enforcement provided by Section 2(f) hereof. 
 (e) Additional Interest. If (i) the Issuer fails to file an Exchange Offer Registration Statement or the Shelf Registration
Statement with respect to the Registrable Securities (other than the Private Exchange Securities, if issued) on or before the date specified herein for such filing, (ii) the Exchange Offer Registration Statement or the Shelf Registration
Statement is not declared effective by the SEC on or prior to the date specified herein for such effectiveness (the “Effectiveness Target Date”), (iii) the Exchange Offer is required to be consummated hereunder and the Issuer
fails to issue Exchange Securities in exchange for all Securities properly tendered and not withdrawn in the Exchange Offer within 45 days of the Effectiveness Target Date with respect to the Exchange Offer Registration Statement, or (iv) the
Exchange Offer Registration Statement or the Shelf Registration Statement required to be filed and declared effective hereunder is declared effective but thereafter ceases to be effective or usable in connection with the Exchange Offer or resales of
Securities, as the case may be, during the periods specified herein (each such event referred to in clauses (i) through (iv) above, a “Registration Default”), then the interest rate borne by the Registrable Securities
(other than the Private Exchange Securities, if issued, as to which no additional amounts shall be payable under this Section 2(e)) as to which the Registration Default exists shall be increased (the “Additional Interest”),
with respect to the first 90-day period (or portion thereof) while a Registration Default 

  

 9 

 
is continuing immediately following the occurrence of such Registration Default, by 0.25% per annum, such interest rate increasing by an additional
0.25 % per annum at the beginning of each subsequent 90-day period (or portion thereof) while a Registration Default is continuing until all Registration Defaults have been cured, up to a maximum rate of Additional Interest of 1.00% per
annum. Upon (1) the filing of the Exchange Offer Registration Statement or the Shelf Registration Statement, as the case may be, required hereunder (in the case of clause (i) of the preceding sentence), (2) the effectiveness of the
Exchange Offer Registration Statement or the Shelf Registration Statement, as the case may be, required hereunder (in the case of clause (ii) of the preceding sentence), (3) the issuance of Exchange Securities in exchange for all
Securities (other than the Private Exchange Securities, if issued) properly tendered and not withdrawn in the Exchange Offer (in the case of clause (iii) of the preceding sentence), or (4) the effectiveness of the Exchange Offer
Registration Statement or the Shelf Registration Statement, as the case may be, required hereunder which had ceased to be effective (in the case of clause (iv) of the preceding sentence), Additional Interest as a result of the Registration
Default described in such clause shall cease to accrue (but any accrued amount shall be payable) and the interest rate on the Securities shall revert to the original rate if no other Registration Default has occurred and is continuing. 

The Issuer shall notify the Trustee within three Business Days after each and every date on which an event occurs in respect of which
Additional Interest is required to be paid (an “Event Date”). Additional Interest shall be paid by depositing with the Trustee, in trust, for the benefit of the Holders of Securities (other than Private Exchange Securities, if
issued) on or before the applicable semi-annual interest payment date, immediately available funds in sums sufficient to pay the Additional Interest then due. The Additional Interest due shall be payable on each interest payment date to the record
Holder of Securities entitled to receive the interest payment to be paid on such date as set forth in the Indenture. Each obligation to pay Additional Interest shall be deemed to accrue from and including the day following the applicable Event Date.

 (f) Specific Enforcement. Without limiting the remedies available to the Initial Purchaser and the Holders, the
Issuer acknowledges that any failure by the Issuer to comply with its obligations under Section 2(a) and Section 2(b) hereof may result in material irreparable injury to the Initial Purchaser or the Holders for which there is no adequate
remedy at law, that it would not be possible to measure damages for such injuries precisely and that, in the event of any such failure, the Initial Purchaser or any Holder may obtain such relief as may be required to specifically enforce the
Issuer’s obligations under Section 2(a) and Section 2(b) hereof. 
 3. Registration Procedures. In connection with the
obligations of the Issuer with respect to the Registration Statements pursuant to Sections 2(a) and 2(b) hereof, the Issuer shall: 
 (a) prepare and file with the SEC a Registration Statement or Registration Statements as prescribed by Sections 2(a) and 2(b) hereof within the relevant time period specified in Section 2 hereof on the appropriate form under the
Securities Act, which form (i) shall be selected by the Issuer, (ii) shall, in the case of a Shelf Registration, be available for the sale of the Registrable Securities by the selling Holders thereof and (iii) shall comply as to form
in all material respects with the requirements of the applicable form and include all 

  

 10 

 
financial statements required by the SEC to be filed therewith; and use its reasonable best efforts to cause such Registration Statement to become effective
and remain effective in accordance with Section 2 hereof; provided, however, that if (1) such filing is pursuant to Section 2(b) or (2) a Prospectus contained in an Exchange Offer Registration Statement filed
pursuant to Section 2(a) is required to be delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Securities, before filing any Registration Statement or Prospectus or any amendments or supplements
thereto, the Issuer shall furnish to and afford the Holders of the Registrable Securities and each such Participating Broker-Dealer, as the case may be, covered by such Registration Statement, their counsel and the managing underwriters, if any, a
reasonable opportunity to review copies of all such documents (excluding copies of any documents to be incorporated by reference therein and all exhibits thereto) proposed to be filed (at least five Business Days prior to such filing). The Issuer
shall not file any Registration Statement or Prospectus or any amendments or supplements thereto in respect of which the Holders must be afforded an opportunity to review prior to the filing of such document if the Majority Holders or such
Participating Broker-Dealer, as the case may be, their counsel or the managing underwriters, if any, shall reasonably object; 
 (b) prepare and file with the SEC such amendments and post-effective amendments to each Registration Statement as may be necessary to keep such Registration Statement effective for the Effectiveness Period or the Applicable Period, as the
case may be; and cause each Prospectus to be supplemented by any required prospectus supplement and as so supplemented to be filed pursuant to Rule 424 (or any similar provision then in force) under the Securities Act, and comply with the provisions
of the Securities Act, the Exchange Act and the rules and regulations promulgated thereunder applicable to it with respect to the disposition of all securities covered by each Registration Statement during the Effectiveness Period or the Applicable
Period, as the case may be, in accordance with the intended method or methods of distribution by the selling Holders thereof described in this Agreement (including sales by any Participating Broker Dealer); 
 (c) in the case of a Shelf Registration, (i) notify each Holder of Registrable Securities, at least three Business Days prior to
filing, that a Shelf Registration Statement with respect to the Registrable Securities is being filed and advising such Holder that the distribution of Registrable Securities will be made in accordance with the method selected by the Majority
Holders, (ii) furnish to each Holder of Registrable Securities and to each underwriter of an underwritten offering of Registrable Securities, if any, without charge, as many copies of each Prospectus, including each preliminary prospectus, and
any amendment or supplement thereto and such other documents as such Holder or underwriter may reasonably request, in order to facilitate the public sale or other disposition of the Registrable Securities, and (iii) subject to the last
paragraph of Section 3(s) hereof, hereby consent to the use of the Prospectus or any amendment or supplement thereto by each of the selling Holders of Registrable Securities in connection with the offering and sale of the Registrable Securities
covered by the Prospectus or any amendment or supplement thereto; 
 (d) in the case of a Shelf Registration, use its
reasonable best efforts to register or qualify the Registrable Securities under all applicable state securities or “blue sky” laws of such jurisdictions by the time the applicable Registration Statement is declared effective by the SEC as
any Holder of Registrable Securities covered by a Registration Statement and each 

  

 11 

 
underwriter of an underwritten offering of Registrable Securities shall reasonably request in advance of such date of effectiveness, and do any and all other
acts and things which may be reasonably necessary or advisable to enable such Holder and underwriter to consummate the disposition in each such jurisdiction of such Registrable Securities owned by such Holder; provided, however, that
the Issuer shall not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (ii) file any general consent to
service of process or (iii) subject itself to taxation in any such jurisdiction if it is not so subject; 
 (e) in the
case of (1) a Shelf Registration or (2) notification from Participating Broker-Dealers that they will be utilizing the Prospectus contained in the Exchange Offer Registration Statement as provided in Section 3(s) hereof, notify each
Holder of Registrable Securities, or such Participating Broker-Dealers, as the case may be, their counsel and the managing underwriters, if any, promptly and confirm such notice in writing (i) when a Registration Statement has become effective
and when any post-effective amendments and supplements thereto become effective, (ii) of any request by the SEC or any state securities authority for amendments and supplements to a Registration Statement or Prospectus or for additional
information after the Registration Statement has become effective, (iii) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of, a Registration Statement or the initiation of any
proceedings for that purpose, (iv) if the Issuer receives any notification with respect to the suspension of the qualification of the Registrable Securities or the Exchange Securities to be sold by any Participating Broker-Dealer for offer or
sale in any jurisdiction or the initiation of any proceeding for such purpose, (v) of the happening of any event or the failure of any event to occur or the discovery of any facts or otherwise during the Effectiveness Period or Applicable
Period, as the case may be, which makes any statement made in a Registration Statement or the related Prospectus untrue in any material respect or which causes such Registration Statement or Prospectus to omit to state a material fact necessary to
make the statements therein (in the case of the Prospectus, in the light of the circumstances under which they were made) not misleading and (vi) of the Issuer’s reasonable determination that a post-effective amendment to the Registration
Statement would be appropriate; 
 (f) take reasonable efforts to obtain the withdrawal of any order suspending the
effectiveness of a Registration Statement as soon as practicable; 
 (g) In the case of a Shelf Registration, furnish to each
Holder of Registrable Securities, without charge, at least one conformed copy of each Registration Statement relating to such Shelf Registration and any post-effective amendment thereto (without documents incorporated therein by reference or
exhibits thereto, unless requested); 
 (h) in the case of a Shelf Registration, cooperate with the selling Holders of
Registrable Securities to facilitate the timely preparation and delivery of certificates representing Registrable Securities sold and not bearing any restrictive legends; and cause such Registrable Securities to be in such denominations (consistent
with the provisions of the Indenture) and registered in such names as the selling Holders or the underwriters may reasonably request at least two Business Days prior to the closing of any sale of Registrable Securities; 
  

 12 

 (i) in the case of a Shelf Registration or an Exchange Offer Registration, upon the
occurrence of any circumstance contemplated by Section 3(e)(ii), 3(e)(iii), 3(e)(v) or 3(e)(vi) hereof, use its reasonable best efforts to prepare a supplement or post-effective amendment to a Registration Statement or the related Prospectus or
any document incorporated therein by reference or file any other required document (subject to Section 3(a)) so that, as thereafter delivered to the purchasers of the Registrable Securities or Exchange Securities to whom a Prospectus is being
delivered by a Participating Broker-Dealer who has notified the Issuer that it will be utilizing the Prospectus contained in the Exchange Offer Registration Statement as provided in Section 3(s) hereof, such Prospectus will not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and to notify each Holder or Participating Broker-Dealer, as
the case may be, to suspend use of the Prospectus as promptly as practicable after the occurrence of such an event, and each Holder and Participating Broker-Dealer hereby agrees to suspend use of the Prospectus until the Issuer has amended or
supplemented the Prospectus to correct such misstatement or omission; 
 (j) in the case of a Shelf Registration, upon the
filing of any document which is to be incorporated by reference into a Registration Statement or a Prospectus after the initial filing of a Registration Statement, provide a reasonable number of copies of such document to the Holders; 
 (k) obtain a CUSIP number for all Exchange Securities or Registrable Securities, as the case may be, not later than the effective date of
a Registration Statement, and provide the Trustee with certificates for the Exchange Securities or the Registrable Securities, as the case may be, in a form eligible for deposit with the Depositary; 
 (l) in the case of a Shelf Registration, enter into such agreements (including underwriting agreements) as are customary in underwritten
offerings and take all such other appropriate actions as are reasonably requested in order to expedite or facilitate the registration or the disposition of such Registrable Securities, and in such connection, whether or not an underwriting agreement
is entered into and whether or not the registration is an underwritten registration, at the time of effectiveness of such Shelf Registration: (i) make such representations and warranties to Holders of such Registrable Securities and the
underwriters (if any), with respect to the business of the Issuer and its subsidiaries as then conducted or proposed to be conducted and the Registration Statement, Prospectus and documents, if any, incorporated or deemed to be incorporated by
reference therein, in each case, in form and substance similar to the representations and warranties given by the Issuer in the Purchase Agreement and reasonably satisfactory to the managing underwriters (if any) and the Holders of a majority in
principal amount of the Registrable Securities being sold, and confirm the same if and when requested; (ii) obtain opinions of counsel to the Issuer and the Guarantor and updates thereof, if appropriate, in form and substance similar to the
opinion given by counsel to the Issuer and the Guarantor pursuant to the Purchase Agreement and reasonably satisfactory to the managing underwriters (if any) and the Holders of a majority in principal amount of the Registrable Securities being sold,
addressed to each selling Holder and the underwriters (if any); (iii) obtain “cold comfort” letters and updates thereof in form and substance reasonably satisfactory to the managing underwriters (if any) from the independent certified
public accountants of the Issuer and the Guarantor (and, if necessary, any other independent certified public accountants of any subsidiary of the Issuer or 

  

 13 

 
of any business acquired by the Issuer for which financial statements and financial data are, or are required to be, included in the Registration Statement),
addressed to the selling Holders of Registrable Securities (if appropriate) and to each of the underwriters (if any), such letters to be in customary form and covering matters of the type customarily covered in “cold comfort” letters in
connection with underwritten offerings and such other matters as reasonably requested by such selling Holders and underwriters; and (iv) if an underwriting agreement is entered into, the same shall contain indemnification provisions and
procedures no less favorable than those set forth in Section 4 hereof (or such other less favorable provisions and procedures acceptable to Holders of a majority in aggregate principal amount of Registrable Securities covered by such
Registration Statement and the managing underwriters or agents) with respect to all parties to be indemnified pursuant to said Section (including, without limitation, such underwriters and selling Holders); the above shall be done at each closing
under such underwriting agreement, or as and to the extent required thereunder; 
 (m) if (1) a Shelf Registration is
filed pursuant to Section 2(b) or (2) a Prospectus contained in an Exchange Offer Registration Statement filed pursuant to Section 2(a) is required to be delivered under the Securities Act by any Participating Broker-Dealer who seeks
to sell Exchange Securities during the Applicable Period, make available for inspection by any selling Holder of such Registrable Securities being sold, or each such Participating Broker Dealer, as the case may be, any underwriter participating in
any such disposition of Registrable Securities, if any, and any attorney, accountant or other agent retained by any such selling Holder or each such Participating Broker-Dealer, as the case may be, or underwriter (collectively, the
“Inspectors”), at the offices where normally kept, during reasonable business hours, all financial and other records, pertinent corporate documents and properties of the Issuer, the Guarantor and the other subsidiaries of Guarantor
(collectively, the “Records”) as shall be reasonably necessary to enable them to exercise any applicable due diligence responsibilities, and cause the officers, directors and employees of the Issuer, the Guarantor and the other
subsidiaries of the Guarantor to supply all information in each case reasonably requested by any such Inspector in connection with such Registration Statement; Records which the Issuer or the Guarantor determines to be confidential or any Records
which they notify the Inspectors are confidential shall not be disclosed by the Inspectors unless (i) the disclosure of such Records is necessary in connection with the Inspectors’ assertion of any claims or actions or with their
establishment of any defense in an action then pending before a court of competent jurisdiction, (ii) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction or (iii) the
information in such Records has been made generally available to the public; each selling Holder of such Registrable Securities and each such Participating Broker-Dealer will be required to agree that information obtained by it as a result of such
inspections shall be deemed confidential and shall not be used by it as the basis for any market transactions in the securities of the Issuer unless and until such is made generally available to the public; each selling Holder of such Registrable
Securities and each such Participating Broker-Dealer will be required to further agree that it will, prior to disclosure of such Records pursuant to clause (i) or (ii) above, give prompt notice to the Issuer and the Guarantor and allow the
Issuer and the Guarantor at their expense to undertake appropriate action to prevent disclosure to the public of the Records deemed confidential; 
  

 14 

 (n) comply with all applicable rules and regulations of the SEC and make generally
available to its security holders earnings statements satisfying the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar rule promulgated under the Securities Act) no later than 180 days after the end of
any 12-month period (i) commencing at the end of any fiscal quarter in which Registrable Securities are sold to underwriters in a firm commitment or reasonable best efforts underwritten offering and (ii) if not sold to underwriters in such
an offering, commencing on the first day of the first fiscal quarter of the Issuer after the effective date of a Registration Statement, which statements shall cover said 12-month period; 
 (o) upon consummation of an Exchange Offer or a Private Exchange, obtain an opinion of counsel to the Issuer and the Guarantor addressed
to the Trustee for the benefit of all Holders of Registrable Securities participating in the Exchange Offer or the Private Exchange, as the case may be, and which includes an opinion that (i) the Issuer has duly authorized, executed and
delivered the Exchange Securities and Private Exchange Securities and the Indenture, and (ii) each of the Exchange Securities or the Private Exchange Securities, as the case may be, and the Indenture constitute a legal, valid and binding
obligation of the Issuer and the Guarantor, enforceable against the Issuer and the Guarantor in accordance with its respective terms (in each case, with customary exceptions); 
 (p) if an Exchange Offer or a Private Exchange is to be consummated, upon delivery of the Registrable Securities by Holders to the Issuer
(or to such other Person as directed by the Issuer) in exchange for the Exchange Securities or the Private Exchange Securities, as the case may be, the Issuer shall mark, or cause to be marked, on such Registrable Securities delivered by such
Holders that such Registrable Securities are being cancelled in exchange for the Exchange Securities or the Private Exchange Securities, as the case may be; in no event shall such Registrable Securities be marked as paid or otherwise satisfied;

 (q) cooperate with each seller of Registrable Securities covered by any Registration Statement and each underwriter, if
any, participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with the NASD; 
 (r) use its reasonable best efforts to take all other steps necessary to effect the registration of the Registrable Securities covered by
a Registration Statement contemplated hereby; 
 (s) (A) in the case of the Exchange Offer Registration Statement
(i) include in the Exchange Offer Registration Statement a section entitled “Plan of Distribution,” which section shall be reasonably acceptable to the Initial Purchaser or another representative of the Participating Broker-Dealers,
and which shall contain a summary statement of the positions taken or policies made by the staff of the SEC with respect to the potential “underwriter” status of any broker-dealer (a “Participating Broker-Dealer”) that
holds Registrable Securities acquired for its own account as a result of market-making activities or other trading activities and that will be the beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of Exchange Securities to be
received by such broker-dealer in the Exchange Offer, whether such positions or policies have been publicly disseminated by the staff of the SEC or such positions or policies, in the reasonable judgment of the Initial Purchaser or such other
representative, represent the prevailing views of the staff of the SEC, including a statement that any such broker-dealer who receives Exchange Securities for Registrable Securities pursuant to the Exchange Offer may be 

  

 15 

 
deemed a statutory underwriter and must deliver a Prospectus meeting the requirements of the Securities Act in connection with any resale of such Exchange
Securities, (ii) furnish to each Participating Broker-Dealer who has delivered to the Issuer the notice referred to in Section 3(e), without charge, as many copies of each Prospectus included in the Exchange Offer Registration Statement,
including any preliminary prospectus, and any amendment or supplement thereto, as such Participating Broker-Dealer may reasonably request, (iii) hereby consent to the use of the Prospectus forming part of the Exchange Offer Registration
Statement or any amendment or supplement thereto, by any Person subject to the prospectus delivery requirements of the SEC, including all Participating Broker-Dealers, in connection with the sale or transfer of the Exchange Securities covered by the
Prospectus or any amendment or supplement thereto, (iv) use its reasonable best efforts to keep the Exchange Offer Registration Statement effective and to amend and supplement the Prospectus contained therein in order to permit such Prospectus
to be lawfully delivered by all Persons subject to the prospectus delivery requirements of the Securities Act for such period of time as such Persons must comply with such requirements in order to resell the Exchange Securities (provided,
however, that such period shall not be required to exceed 180 days (or such longer period if extended pursuant to the last sentence of this Section 3(s) hereof) (the “Applicable Period”)), and (v) include in the
transmittal letter or similar documentation to be executed by an exchange offeree in order to participate in the Exchange Offer (x) the following provision: 
 “If the exchange offeree is a broker-dealer holding Registrable Securities acquired for its own account as a result of marketmaking activities or other trading activities, it will deliver a prospectus meeting the
requirements of the Securities Act in connection with any resale of Exchange Securities received in respect of such Registrable Securities pursuant to the Exchange Offer;” 
 and (y) a statement to the effect that by a Participating Broker-Dealer making the acknowledgment described in clause (x) and by delivering a
Prospectus in connection with the exchange of Registrable Securities, such Participating Broker-Dealer will not be deemed to admit that it is an underwriter within the meaning of the Securities Act; and 
 (B) in the case of any Exchange Offer Registration Statement, deliver to the Initial Purchaser or to Participating Broker-Dealers upon
consummation of the Exchange Offer (i) an opinion of counsel substantially in the form attached hereto as
 Exhibit A, and (ii) an officers’ certificate containing certifications substantially similar to those set forth in
Section 5(c) of the Purchase Agreement and such additional certifications as are customarily delivered in a public offering of debt securities. 
 The Issuer may require each seller of Registrable Securities as to which any registration is being effected to furnish to the Issuer such information regarding such seller and the proposed distribution of such
Registrable Securities, as the Issuer may from time to time reasonably request in writing. The Issuer may exclude from such registration the Registrable Securities of any seller who fails to furnish any such information which the Issuer reasonably
requires in order for the Shelf Registration Statement to comply with applicable law and SEC policy within a reasonable time after receiving such request (without the accrual of Additional Interest on such excluded Registrable Securities) and shall
be under no obligation to include the 

  

 16 

 
Registrable Securities of such seller in the Shelf Registration Statement or to compensate any such seller for any lost income, interest or other opportunity
foregone, or any liability incurred, as a result of the Issuer’s decision to exclude such seller. 
 In the case of
(1) a Shelf Registration Statement or (2) Participating Broker- Dealers who have notified the Issuer that they will be utilizing the Prospectus contained in the Exchange Offer Registration Statement as provided in this Section 3(s)
that are seeking to sell Exchange Securities and are required to deliver Prospectuses, each Holder or Participating Broker-Dealer, as the case may be, agrees that, upon receipt of any notice from the Issuer of the happening of any event of the kind
described in Section 3(e)(ii), 3(e)(iii), 3(e)(v) or 3(e)(vi) hereof, such Holder or Participating Broker-Dealer, as the case may be, will forthwith discontinue disposition of Registrable Securities pursuant to a Registration Statement or
Exchange Securities, as the case may be, until such Holder’s or Participating Broker-Dealer’s, as the case may be, receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3(i) hereof or until it is
advised in writing (the “Advice”) by the Issuer that the use of the applicable Prospectus may be resumed, and, if so directed by the Issuer, such Holder or Participating Broker-Dealer, as the case may be, will deliver to the Issuer
(at the Issuer’s expense) all copies in such Holder’s or Participating Broker-Dealer’s, as the case may be, possession, other than one permanent file copy then in such Holder’s or Participating Broker Dealer’s, as the case
may be, possession, of the Prospectus covering such Registrable Securities or Exchange Securities, as the case may be, current at the time of receipt of such notice. If the Issuer shall give any such notice to suspend the disposition of Registrable
Securities or Exchange Securities, as the case may be, pursuant to a Registration Statement: (x) the Issuer shall use its reasonable best efforts to file and have declared effective (if an amendment) as soon as practicable an amendment or
supplement to the Registration Statement and, in the case of an amendment, have such amendment declared effective as soon as practicable; provided, however, that the Issuer may postpone the filing of such amendment or supplement for a
period not to extend beyond the earlier to occur of (I) 30 days after the date of the determination of the Board of Directors and (II) the day after the cessation of the circumstances upon which such postponement is based, if the members of the
Issuer determine reasonably and in good faith that such filing would require disclosure of material information which the Issuer has a bona fide purpose for preserving as confidential; provided, further, however, that the Issuer shall
be entitled to such postponement only once during any 12-month period and the exercise by the Issuer of its rights under this provision shall not relieve the Issuer of any obligation to pay Additional Interest under Section 2(e) hereof; and
(y) the Issuer shall extend the period during which such Registration Statement shall be maintained effective pursuant to this Agreement by the number of days in the period from and including the date of the giving of such notice to and
including the date when the Issuer shall have made available to the Holders or Participating Broker-Dealers, as the case may be, copies of the supplemented or amended Prospectus necessary to resume such dispositions or the Advice. 
  

 17 

 4. Indemnification and Contribution. (a) The Issuer agrees to indemnify and hold harmless the
Initial Purchaser, each Holder, each Participating Broker-Dealer, each underwriter who participates in an offering of Registrable Securities, their respective affiliates, each Person, if any, who controls any of such parties within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act and each of their respective directors, officers, employees and agents, as follows: 
 (i) against any and all loss, liability, claim, damage and expense whatsoever, joint or several, as incurred, arising out of any untrue
statement or alleged untrue statement of a material fact contained in any Registration Statement (or any amendment or supplement thereto), covering Registrable Securities or Exchange Securities, including all documents incorporated therein by
reference, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement of a material
fact contained in any Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; 
 (ii) against any and all loss, liability, claim, damage and expense whatsoever, joint or several, as
incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any court or governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue
statement or omission, or any such alleged untrue statement or omission, if such settlement is effected with the prior written consent of the Issuer; and 
 (iii) against any and all expenses whatsoever, as incurred (including reasonable fees and disbursements of one counsel chosen by the Initial Purchaser, such Holder, such Participating Broker-Dealer or any underwriter
(except to the extent otherwise expressly provided in Section 4(c) hereof)), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any court or governmental agency or body,
commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) of this
Section 4(a); 
 provided, however, that this indemnity does not apply to any loss, liability, claim, damage or expense to the extent
arising out of an untrue statement or omission or alleged untrue statement or omission (1) made in reliance upon and in conformity with written information furnished in writing to the Issuer or the Guarantor by the Initial Purchaser, such
Holder, such Participating Broker-Dealer or any underwriter with respect to the Initial Purchaser, Holder, Participating Broker-Dealer or underwriter, as the case may be, expressly for use in the Registration Statement (or any amendment or
supplement thereto) or in any Prospectus (or any amendment or supplement thereto) or (2) contained in any preliminary prospectus if the Initial Purchaser, such Holder, such Participating Broker-Dealer or such underwriter failed to send or
deliver a copy of the Prospectus (in the form it was first provided to such parties for confirmation of sales or as amended or supplemented pursuant to Section 3(i) hereof prior to such confirmation of sales) to the Person asserting such
losses, claims, damages or liabilities on or prior to the delivery of written confirmation of any sale of securities covered thereby to such Person in any case where such delivery is required by the Securities Act and a court of competent
jurisdiction in a judgment not subject to appeal or final review shall have determined that such Prospectus would have corrected such untrue statement or omission. Any amounts advanced by the Issuer to an indemnified party pursuant to this
Section 4 as a result of such losses shall be returned to the Issuer if it shall be finally determined by such a court in a judgment not subject to appeal or final review that such indemnified party was not entitled to indemnification by the
Issuer. 
  

 18 

 (b) Each Holder agrees, severally and not jointly, to indemnify and hold harmless the
Issuer, the Guarantor, the Initial Purchaser, each underwriter who participates in an offering of Registrable Securities and the other selling Holders and each of their respective directors, officers (including each officer of the Issuer who signed
the Registration Statement), employees and agents and each Person, if any, who controls the Issuer, the Guarantor, the Initial Purchaser, any underwriter or any other selling Holder within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and expense whatsoever described in the indemnity contained in Section 4(a) hereof, as incurred, but only with respect to untrue statements or omissions, or
alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto) or in any Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with written information furnished to the Issuer
or the Guarantor by such selling Holder with respect to such Holder expressly for use in the Registration Statement (or any supplement thereto), or in any such Prospectus (or any amendment thereto); provided, however, that, in the case
of the Shelf Registration Statement, no such Holder shall be liable for any claims hereunder in excess of the amount of net proceeds received by such Holder from the sale or other disposition of Registrable Securities pursuant to the Shelf
Registration Statement. 
 (c) Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is
not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. In the case of parties indemnified pursuant to Section 4(a) above,
counsel to the indemnified parties shall be selected by the Initial Purchaser, and, in the case of parties indemnified pursuant to Section 4(b) above, counsel to the indemnified parties shall be selected by the Issuer. An indemnifying party may
participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. If it so
elects within a reasonable time after receipt of such notice, an indemnifying party, jointly with any other indemnifying parties receiving such notice, may assume the defense of such action with counsel chosen by it and approved by the indemnified
parties defendant in such action, unless such indemnified parties reasonably object to such assumption on the ground that there may be legal defenses available to them which are different from or in addition to those available to such indemnifying
party. If an indemnifying party assumes the defense of such action, the indemnifying parties shall not be liable for any fees and expenses of counsel for the indemnified parties incurred thereafter in connection with such action. In no event shall
the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with anyone action or separate but similar or related
actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment
with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or 

  

 19 

 
any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 4 (whether or not the indemnified parties
are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 
 (d) If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable
for any settlement of the nature contemplated by Section 4(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request,
(ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in
accordance with such request prior to the date of such settlement. Notwithstanding the immediately preceding sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and
expenses of counsel, such indemnifying party shall not be liable for any settlement of the nature contemplated by Section 4(a)(ii) effected without its prior written consent if such indemnifying party (1) reimburses such indemnified party
in accordance with such request to the extent it considers such request to be reasonable and (2) provides written notice to the indemnified party substantiating the unpaid balance as unreasonable, in each case prior to the date of such
settlement. 
 (e) In order to provide for just and equitable contribution in circumstances under which any of the indemnity
provisions set forth in this Section 4 is for any reason held to be unavailable to the indemnified parties although applicable in accordance with its terms, the Issuer and the Holders shall contribute to the aggregate losses, liabilities,
claims, damages and expenses of the nature contemplated by such indemnity agreement incurred by the Issuer, the Guarantor, the Initial Purchaser, the Holders and the Participating Broker-Dealers; provided, however, that no Person
guilty of fraudulent misrepresentation (within the meaning of Section 11 (f) of the Securities Act) shall be entitled to contribution from any Person that was not guilty of such fraudulent misrepresentation. As between the Issuer, the
Guarantor and the Holders, such parties shall contribute to such aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by such indemnity agreement in such proportion as shall be appropriate to reflect the relative
fault of the Issuer and the Guarantor on the one hand and of the Holder of Registrable Securities, the Participating Broker-Dealer or the Initial Purchaser, as the case may be, on the other hand in connection with the statements or omissions which
resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations. 
 The relative fault of the Issuer and the Guarantor on the one hand and the Holder of Registrable Securities, the Participating Broker-Dealer or the Initial Purchaser, as the case may be, on the other hand shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Issuer, or the Guarantor, or by the Holder of Registrable
Securities, the Participating Broker-Dealer or the Initial Purchaser, as the case may be, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
  

 20 

 The Issuer, the Guarantor and the Holders of the Registrable Securities and the Initial
Purchaser agree that it would not be just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred
to above in this Section 4. 
 For purposes of this Section 4, each affiliate of the Initial Purchaser or Holder,
and each director, officer, employee, agent and Person, if any, who controls a Holder of Registrable Securities, the Initial Purchaser or a Participating Broker-Dealer within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act shall have the same rights to contribution as such other Person, and each member or director of the Issuer or the Guarantor, as the case may be, each officer of the Issuer who signed the Registration Statement, and each Person, if
any, who controls the Issuer or the Guarantor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Issuer or the Guarantor, as the case may be.

 5. Participation in Underwritten Registrations. No Holder may participate in any underwritten registration hereunder unless such
Holder (a) agrees to sell such Holder’s Registrable Securities on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to approve such arrangements and (b) completes and executes all
reasonable questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements. The Issuer shall be under no obligation to compensate any Holder for lost
income, interest or other opportunity foregone, or other liability incurred, as a result of the Issuer’s decision to exclude such Holder from any underwritten registration if such Holder has not complied with the provisions of this
Section 5 in all material respects following five business days’ written notice of noncompliance and the Issuer’s decision to exclude such Holder. 
 6. Selection of Underwriters. The Holders of Registrable Securities covered by the Shelf Registration Statement who desire to do so may sell the securities covered by such Shelf Registration in an underwritten
offering. In any such underwritten offering, the underwriter or underwriters and manager or managers that will administer the offering will be selected by the Holders of a majority in aggregate principal amount of the Registrable Securities included
in such offering; provided, however, that such underwriters and managers must be reasonably satisfactory to the Issuer. 
 7.
Guarantor. The parties to this Agreement agree and acknowledge that all obligations of the Issuer under this Agreement are joint and several obligations of the Issuer and the Guarantor. 
 8. Miscellaneous. 
 (a) Rule 144 and Rule 144A. For so long as the Issuer is subject to the reporting requirements of Section 13 or 15 of the Exchange Act and any Registrable Securities remain outstanding, the Issuer covenants that it will file the
reports required to be filed by it 

  

 21 

 
under the Securities Act and Section 13(a) or 15(d) of the Exchange Act and the rules and regulations adopted by the SEC thereunder, that if it ceases
to be so required to file such reports, it will upon the request of any Holder of Registrable Securities (i) make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the Securities Act,
(ii) deliver such information to a prospective purchaser as is necessary to permit sales pursuant to Rule 144A under the Securities Act, and (iii) take such further action that is reasonable in the circumstances, in each case, to the
extent required from time to time to enable such Holder to sell its Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (1) Rule 144 under the Securities Act, as such rule may
be amended from time to time, (2) Rule 144A under the Securities Act, as such rule may be amended from time to time, or (3) any similar rules or regulations hereafter adopted by the SEC. Upon the reasonable request of any Holder of
Registrable Securities, the Issuer will deliver to such Holder a written statement as to whether it has complied with such requirements. 
 (b) No Inconsistent Agreements. The Issuer has not entered into nor will the Issuer on or after the date of this Agreement enter into any agreement which is inconsistent with the rights granted to the Holders
of Registrable Securities in this Agreement or otherwise conflicts with the provisions hereof. The rights granted to the Holders hereunder do not in any way conflict with and are not inconsistent with the rights granted to the holders of the
Issuer’s other issued and outstanding securities under any such agreements. 
 (c) Amendments and Waivers. The
provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, otherwise than with the prior written consent
of the Issuer and the Majority Holders; provided, however, that no amendment, modification, or supplement or waiver or consent to the departure with respect to the provisions of Section 4 hereof shall be effective as against any
Holder of Registrable Securities unless consented to in writing by such Holder of Registrable Securities. 
 (d)
Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand-delivery, registered first-class mail, telecopier, or any courier guaranteeing overnight delivery: (i) if to a Holder, at
the most current address given by such Holder to the Issuer by means of a notice given in accordance with the provisions of this Section 8(d), which address initially is, with respect to the Initial Purchaser, the address set forth in the
Purchase Agreement; and (ii) if to the Issuer or the Guarantor, initially at the Issuer’s and the Guarantor’s address set forth in the Purchase Agreement and thereafter at such other address, notice of which is given in accordance
with the provisions of this Section 8(d). 
 All such notices and communications shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when receipt is acknowledged, if telecopied; and on the next Business Day, if timely delivered to an air
courier guaranteeing overnight delivery. 
 Copies of all such notices, demands, or other communications shall be concurrently
delivered by the Person giving the same to the Trustee, at the address specified in the Indenture. 
  

 22 

 (e) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors, assigns and transferees of the Initial Purchaser, including, without limitation and without the need for an express assignment, subsequent Holders; provided, however, that nothing herein shall be deemed to
permit any assignment, transfer or other disposition of Registrable Securities in violation of the terms of the Purchase Agreement or the Indenture. If any transferee of any Holder shall acquire Registrable Securities, in any manner, whether by
operation of law or otherwise, such Registrable Securities shall be held subject to all of the terms of this Agreement, and by taking and holding such Registrable Securities, such Person shall be conclusively deemed to have agreed to be bound by and
to perform all of the terms and provisions of this Agreement and such Person shall be entitled to receive the benefits hereof. 
 (f) Third Party Beneficiary. The Initial Purchaser shall be a third party beneficiary of the agreements made hereunder between the Issuer or the Guarantor, on the one hand, and the Holders, on the other hand, and shall have the right
to enforce such agreements directly to the extent it deems such enforcement necessary or advisable to protect its rights or the rights of Holders hereunder. 
 (g) Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts,
each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
 (h) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 
 (i) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT
GIVING EFFECT TO ANY PROVISIONS RELATING TO CONFLICTS OF LAWS. Specified times of day refer to New York City time. 
 (j)
Severability. In the event that anyone or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in
every other respect and of the remaining provisions contained herein shall not be affected or impaired thereby. 
 (k)
Securities Held by the Issuer or any of its Affiliates. Whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, Registrable Securities held by the Issuer or any of its affiliates
(as such term is defined in Rule 405 under the Securities Act) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage. 
 [Signature Pages Follow] 
  

 23 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

					
	NEWS AMERICA INCORPORATED
		
	By:	 	/s/ Janet Nova
		 	Name:	 	Janet Nova
		 	Title:	 	Authorized Signatory

  

					
	NEWS CORPORATION
		
	By:	 	/s/ Janet Nova
		 	Name:	 	Janet Nova
		 	Title:	 	Authorized Signatory

			
	 CONFIRMED AND ACCEPTED,
 as of the date first
above written:

	
	J.P. MORGAN SECURITIES INC.
		
	By	 	/s/ Robert Bottamedi
		 	Authorized Signatory
		 	Robert Bottamedi
		 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]